USFDA concludes inspection at Cadila Healthcare’s manufacturing facility in Ahmedabad

03 Apr 2019 Evaluate

United States Food and Drug Administration (USFDA) has concluded inspection at Cadila Healthcare’s manufacturing facility located at Pharmez in Ahmedabad with one observation. The inspection was conducted from March 25, 2019 to April 02, 2019. The inspection includes product specific pre-approval and post approval inspections and a GMP inspection.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×